| If this is not your name, click here. | | |
| | Contact Us | Order Now | Journals | Bookstore | Register a colleague | | |
| | | ![]() Updated Guidelines for Childhood Vaccinations BIRMINGHAM, Ala -- January 7, 2010 -- Updated guidelines issued this week for childhood and teen immunisations include formal recommendations that children aged older than 6 months get the influenza A(H1N1) vaccine and that combination vaccines are generally preferred over separate injections. The revised childhood vaccine schedule is published in the January issue of the journal Pediatrics and is issued by the American Academy of Pediatrics, the Centers for Disease Control and Prevention (CDC), and the American Academy of Family Physicians. , ember of the American Academy of Pediatrics Committee on Infectious Diseases and a liaison to the Centers for Disease Control panel that helped author the recommendations. “Most of these recommendations are for vaccines and boosters that almost every paediatrician and family physician knows about and already is using,” said coauthor of the recommendations David Kimberlin, MD, University of Alabama at Birmingham, Birmingham, Alabama. “It is good practice to issue a clear, concise vaccine schedule that anyone can refer to. The bottom line here is vaccines save lives, improve the health of all children and benefit families and communities.” The updated schedule reflects new vaccines approved by the US Food and Drug Administration that include the H1N1 vaccine and a human papillomavirus vaccine for girls, known as the HPV2 vaccine, designed to protect females from 2 strains of the virus associated with more than 70% of cervical cancer cases, said Dr. Kimberlin. The new schedule states it is permissible for doctors to recommend the earlier HPV4 vaccine for boys aged 9 and older, offering protection from 4 strains of the virus and reducing the likelihood of male genital warts. The recommendations also say children considered at-risk for meningococcal disease, especially those with immune-system disorders and other conditions, should get a booster shot of meningococcal conjugate vaccine, known as MCV4, 3 years after their initial MCV4 dose at ages 2 through 6. The update also says that after 4 scheduled doses of inactivated poliovirus vaccine, the fifth dose of the same vaccine should be given on or after age 4 and at least 6 months after the previous dose. Dr. Kimberlin said vaccine considerations always should consider health-care provider assessment, patient preference, and the potential for adverse events. Providers who need more details should refer to the comprehensive recommendations issued by the CDC’s Advisory Committee on Immunisation Practices, available here: http://www.cdc.gov/vaccines/pubs/acip-list.htm Clinically significant adverse events that follow immunisation should be reported to the Vaccine Adverse Event Reporting System at www.vaers.hhs.gov or 800-822-7967. SOURCE: University of Alabama at Birmingham
|